FDA warning letters 2026: patterns in analytical procedure citations
FY2026 FDA warning letters keep citing the same analytical procedure gaps: HPLC audit trails, OOS handling, method validation. What Ava, Intas, Huons and Sanofi Waterford suggest for QC labs.